Observational Study to Evaluate and Compare the Rate and Extent of Inflammation After a Single Intravitreal Injection of Ranibizumab vs. a Single Intravitreal Injection of Aflibercept in Treatment Naive and Treatment Experienced Patients.

NCT01942213 · clinicaltrials.gov ↗
COMPLETED
Status
136
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Prism Vision Group